Literature DB >> 23399331

Endotoxin adsorption by polymyxin B column or intraaortic balloon pumping use for severe septic cardiomyopathy.

Kensuke Nakamura1, Kent Doi, Ryota Inokuchi, Tatsuma Fukuda, Takahiro Hiruma, Takeshi Ishii, Susumu Nakajima, Eisei Noiri, Naoki Yahagi.   

Abstract

Septic patients often have low cardiac output. Some of them present severe cardiac dysfunction such as septic cardiomyopathy. However, no well-known and effective treatment for septic cardiomyopathy exists. The effect of endotoxin adsorption by polymyxin B–immobilized fiber column–direct hemoperfusion (PMX-DHP) and intraaortic balloon pumping (IABP) for septic shock remains uncertain. We experienced 2 very contrastive case reports of severe septic cardiomyopathy. We experienced 2 cases of severe septic cardiomyopathy with refractory shock. Case 1 with colon perforation presented refractory shock 6 hours after PMX-DHP, and IABP immediately improved her hemodynamics. In contrast, IABP had no effect at all in case 2 with viral enteritis, but PMXDHP improved her blood pressure and stroke volume markedly. The probability of impaired coronary microcirculation and relative bradycardia is the least required conditions for IABP use in severe septic cardiomyopathy. Meanwhile, PMX-DHP could be a good option for septic cardiomyopathy because of its fewer complications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399331     DOI: 10.1016/j.ajem.2012.12.042

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Two cases with intra-aortic balloon pumping use for severe septic cardiomyopathy.

Authors:  Taro Hiromi; Chiaki Toida; Takashi Muguruma; Katsutaka Hashiba; Tomoki Doi; Kyota Nakamura; Naoto Morimura
Journal:  Acute Med Surg       Date:  2017-07-13

2.  Effect of Intra-arterial Balloon Pumping for Refractory Septic Cardiomyopathy: A Case Series.

Authors:  Yuji Takahashi; Tomohiro Sonoo; Hiromu Naraba; Hideki Hashimoto; Kensuke Nakamura
Journal:  Indian J Crit Care Med       Date:  2019-04

3.  Alprostadil attenuates LPS-induced cardiomyocyte injury by inhibiting the Wnt5a/JNK/NF-κB pathway.

Authors:  T Yu; D Dong; J Guan; J Sun; M Guo; Q Wang
Journal:  Herz       Date:  2019-07-16       Impact factor: 1.443

Review 4.  A review of sepsis-induced cardiomyopathy.

Authors:  Ryota Sato; Michitaka Nasu
Journal:  J Intensive Care       Date:  2015-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.